ContextVision AB
Research ContextVision AB (CONTX) on Bullrun: valuation model: 46.0% overvalued, market cap NOK 260.78M, P/E 55.1. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCONTX
- ExchangeOL
- CountrySweden
- SectorHealthcare
- IndustryHealth Information Services
- CurrencyNOK
- Valuation signal46.0% overvalued
- Market capNOK 260.78M
- P/E55.1
- Financial periodFY2024
- RevenueSEK 130.67M
- Revenue growth-1.2%
- Net incomeSEK 24.68M
- Free cash flowSEK 29.28M
- Gross margin97.4%
Valuation Snapshot
Bullrun's latest valuation model marks ContextVision AB as 46.0% overvalued; latest market cap is NOK 260.78M; P/E is 55.1.
About ContextVision AB
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally. The company offers image quality solutions for ultrasound, as well as its Rivent platform comprising Rivent, a 2D image enhancement; Rivent Plus, a premium 2D image enhancement product; Rivent 3D, a solution for improving image quality of 3D ultrasound;
Frequently asked questions
Is ContextVision AB overvalued or undervalued?
Bullrun's valuation model currently marks ContextVision AB as 46.0% overvalued.
What is ContextVision AB's market cap?
ContextVision AB's market capitalization is NOK 260.78M.
What is ContextVision AB's P/E ratio?
ContextVision AB's price-to-earnings (P/E) ratio is 55.1.
What does ContextVision AB do?
ContextVision AB (publ), a software company, provides image analysis and imaging for medical systems in South Korea, China, Japan, the United States, and internationally.